{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:13:36Z","timestamp":1790993616227,"version":"4.1.0"},"reference-count":92,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2017.00290","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T00:22:48Z","timestamp":1509063768000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":64,"title":["Vitiligo and Autoimmune Thyroid Disorders"],"prefix":"10.3389","volume":"8","author":[{"given":"Enke","family":"Baldini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Odorisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Sorrenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Catania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Carbotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Pironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rendina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"D\u2019Armiento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severino","family":"Persechino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Ulisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Vitiligo Global Issue Consensus Conference Panelists","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jaad.2010.08.031","article-title":"Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients","volume":"65","author":"Ezzedine","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B3","first-page":"51","article-title":"400 cases of vitiligo. A clinico-therapeutic analysis","volume":"17","author":"Behl","year":"1972","journal-title":"Indian J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/archderm.1977.01640010049006","article-title":"Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark","volume":"113","author":"Howitz","year":"1977","journal-title":"Arch Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/ijd.13198","article-title":"Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades","volume":"55","author":"Amer","year":"2016","journal-title":"Int J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/0019-5154.39745","article-title":"Vitiligo: is it just a dermatological disorder?","volume":"53","author":"Pandve","year":"2008","journal-title":"Indian J Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/bjd.15199","article-title":"Vitiligo and depression: a systematic review and meta-analysis of observational studies","volume":"177","author":"Lai","year":"2016","journal-title":"Br J Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.biopha.2017.05.095","article-title":"A holistic review on the autoimmune disease vitiligo with emphasis on the casual factors","volume":"92","author":"Patel","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"B10","first-page":"125","article-title":"Vitiligo: not simply a skin disease","volume":"15","author":"Ahluwalia","year":"2017","journal-title":"Skinmed"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1468-3083.2006.02106.x","article-title":"Stress in patients with alopecia areata and vitiligo","volume":"21","author":"Manolache","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.coi.2016.09.008","article-title":"Understanding mechanisms of autoimmunity through translational research in vitiligo","volume":"43","author":"Strassner","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"631927","DOI":"10.1155\/2015\/631927","article-title":"Oxidative stress and immune system in vitiligo and thyroid diseases","volume":"2015","author":"Colucci","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/NEJMcp0804388","article-title":"Vitiligo","volume":"360","author":"Taieb","year":"2009","journal-title":"New Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000131485","article-title":"Autoimmune etiology of generalized vitiligo","volume":"10","author":"Le Poole","year":"2008","journal-title":"Curr Dir Autoimmun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.12688\/f1000research.8976.1","article-title":"Recent advances in understanding vitiligo","volume":"5","author":"Manga","year":"2016","journal-title":"F1000Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/jid.2015.92","article-title":"A new view of vitiligo: looking at normal-appearing skin","volume":"135","author":"Picardo","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.09.003","article-title":"Vitiligo: how do oxidative stress-induced autoantigens trigger autoimmunity?","volume":"81","author":"Xie","year":"2016","journal-title":"J Dermatol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4103\/0378-6323.48427","article-title":"Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin","volume":"75","author":"Sravani","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1111\/jcmm.12874","article-title":"Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations","volume":"20","author":"Song","year":"2016","journal-title":"J Cell Mol Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/jid.2014.152","article-title":"Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo","volume":"134","author":"Jian","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jid.2017.01.020","article-title":"Simvastatin protects human melanocytes from H2O2-induced oxidative stress by activating Nrf2","volume":"137","author":"Chang","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/1523-1747.ep12480976","article-title":"Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients","volume":"97","author":"Boissy","year":"1991","journal-title":"J Invest Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1242\/jcs.153643","article-title":"Redox controls UPR to control redox","volume":"127","author":"Eletto","year":"2014","journal-title":"J Cell Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/jid.2012.181","article-title":"Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8","volume":"132","author":"Toosi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1086\/430279","article-title":"A novel linkage to generalized vitiligo on 4q13-q21 identified in a genome-wide linkage analysis of Chinese families","volume":"76","author":"Chen","year":"2005","journal-title":"Am J Hum Genet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1000523","DOI":"10.1371\/journal.pgen.1000523","article-title":"Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo","volume":"5","author":"Ren","year":"2009","journal-title":"PLoS Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/jid.2010.337","article-title":"Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP","volume":"131","author":"Birlea","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.molcel.2007.06.011","article-title":"XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks","volume":"27","author":"Acosta-Alvear","year":"2007","journal-title":"Mol Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigement Cell Melanoma Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","article-title":"Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo","volume":"97","author":"Harning","year":"1991","journal-title":"J Invest Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1600-0560.1984.tb00361.x","article-title":"Immunopathology of vitiligo vulgaris, Sutton\u2019s leukoderma and melanoma-associated vitiligo in relation to steroid effects. II. The IgG and C3 deposits in the skin","volume":"11","author":"Uda","year":"1984","journal-title":"J Cutaneous Pathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1046\/j.1365-2249.1998.00746.x","article-title":"Autoantibodies to human melanocyte-specific protein Pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA)","volume":"114","author":"Kemp","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1172\/JCI0214643","article-title":"The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo","volume":"109","author":"Kemp","year":"2002","journal-title":"J Clin Invest"},{"key":"B37","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.autrev.2017.07.006","article-title":"Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis","volume":"16","author":"Ferrari","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2340\/00015555-2080","article-title":"Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes: a pivotal role of CD8+ cytotoxic T lymphocytes in vitiligo","volume":"95","author":"Yang","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.3978\/j.issn.2305-5839.2015.03.02","article-title":"The role of the Th1 chemokine CXCL10 in vitiligo","volume":"3","author":"Antonelli","year":"2015","journal-title":"Ann Transl Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1177\/039463201002300424","article-title":"The presence of non-segmental vitiligo modifies intracellular cytokine subsets in patients with chronic lymphocytic thyroiditis","volume":"23","author":"Santaguida","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e18907","DOI":"10.1371\/journal.pone.0018907","article-title":"Th17\u2009cells and activated dendritic cells are increased in vitiligo lesions","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1755-148X.2011.00945.x","article-title":"Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17\u2009cell infiltration in autoimmune vitiligo vulgaris","volume":"25","author":"Kotobuki","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","article-title":"Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics","volume":"14","author":"Dwivedi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1096\/fj.10-162156","article-title":"Expression and signaling of the tyrosine kinase FGFR2b\/KGFR regulates phagocytosis and melanosome uptake in human keratinocytes","volume":"25","author":"Belleudi","year":"2011","journal-title":"FASEB J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0854.2006.00425.x","article-title":"The quest for the mechanism of melanin transfer","volume":"7","author":"Van Den Bossche","year":"2006","journal-title":"Traffic"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1111\/jcmm.12411","article-title":"Decreased expression of KGF\/FGF7 and its receptor in pathological hypopigmentation","volume":"18","author":"Purpura","year":"2014","journal-title":"J Cell Mol Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.autrev.2013.07.006","article-title":"Autoimmune polyendocrine syndromes","volume":"13","author":"Cutolo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1365-2133.1968.tb12282.x","article-title":"Vitiligo, thyroid disease and autoimmunity","volume":"80","author":"Cunliffe","year":"1968","journal-title":"Br J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/1346-8138.12147","article-title":"Modern vitiligo genetics sheds new light on an ancient disease","volume":"40","author":"Spritz","year":"2013","journal-title":"J Dermatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jaad.2015.08.063","article-title":"Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study","volume":"74","author":"Gill","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1600-0749.2005.00242.x","article-title":"Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo","volume":"18","author":"Laberge","year":"2005","journal-title":"Pigment Cell Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-4362.1996.tb01610.x","article-title":"Profile of alopecia areata in Northern India","volume":"35","author":"Sharma","year":"1996","journal-title":"Int J Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1525-1470.1996.tb00703.x","article-title":"A clinical study of childhood alopecia areata in Chandigarh, India","volume":"13","author":"Sharma","year":"1996","journal-title":"Pediatr Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000354607","article-title":"Comorbidities associated with vitiligo: a ten-year retrospective study","volume":"227","author":"Sheth","year":"2013","journal-title":"Dermatology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1684\/ejd.2009.0939","article-title":"Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases","volume":"20","author":"Amerio","year":"2010","journal-title":"Eur J Dermatol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2332\/allergolint.11-OA-0303","article-title":"Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families","volume":"60","author":"Narita","year":"2011","journal-title":"Allergol Int"},{"key":"B61","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jaad.2010.08.032","article-title":"Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study","volume":"65","author":"Chu","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamadermatol.2013.3049","article-title":"Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States","volume":"149","author":"Huang","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1006\/jaut.1995.0009","article-title":"Associated autoimmunity in Addison\u2019s disease","volume":"8","author":"Zelissen","year":"1995","journal-title":"J Autoimmun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2133.1970.tb12428.x","article-title":"Integumentary associations of pernicious anemia","volume":"82","author":"Dawber","year":"1970","journal-title":"Br J Dermatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/archderm.1970.04000010084015","article-title":"Vitiligo and pernicious anemia","volume":"101","author":"Grunnet","year":"1970","journal-title":"Arch Dermatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.autrev.2016.09.009","article-title":"The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients","volume":"15","author":"Fallahi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B67","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1530\/EJE-16-0737","article-title":"Autoimmune comorbidities in Hashimoto\u2019s thyroiditis: different patterns of association in adulthood and childhood\/adolescence","volume":"176","author":"Ruggeri","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"435947","DOI":"10.1155\/2015\/435947","article-title":"The frequency of autoimmune thyroid disease in alopecia areata and vitiligo patients","volume":"2015","author":"Saylam Kurtipek","year":"2015","journal-title":"Biomed Res Int"},{"key":"B69","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3923\/pjbs.2013.570.574","article-title":"Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population","volume":"16","author":"Nejad","year":"2013","journal-title":"Pak J Biol Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/bjd.13286","article-title":"High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients","volume":"171","author":"Colucci","year":"2014","journal-title":"Br J Dermatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"8065765","DOI":"10.1155\/2016\/8065765","article-title":"Adult onset vitiligo: multivariate analysis suggests the need for a thyroid screening","volume":"2016","author":"Lazzeri","year":"2016","journal-title":"Biomed Res Int"},{"key":"B72","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jaad.2016.12.034","article-title":"Vitiligo and overt thyroid diseases: a nationwide population-based study in Korea","volume":"76","author":"Bae","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"192736","DOI":"10.1155\/2015\/192736","article-title":"Anti-thyroid peroxidase antibody in vitiligo: a prevalence study","volume":"2015","author":"Dash","year":"2015","journal-title":"J Thyroid Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/j.1365-2133.2012.11198.x","article-title":"The prevalence of thyroid disease in patients with vitiligo: a systematic review","volume":"167","author":"Vrijman","year":"2012","journal-title":"Br J Dermatol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00244-015-0138-7","article-title":"Correlation of serum thyroid hormones autoantibodies with self-reported exposure to thyroid disruptors in a group of nonsegmental vitiligo patients","volume":"69","author":"Colucci","year":"2015","journal-title":"Arch Environ Contam Toxicol"},{"key":"B76","first-page":"89","article-title":"Vitiligo in autoimmune thyroid disease","volume":"3","author":"Shong","year":"1991","journal-title":"Thyroidology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejim.2007.09.021","article-title":"Skin findings in thyroid diseases","volume":"20","author":"Artanta\u015f","year":"2009","journal-title":"Eur J Intern Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jaad.2016.04.029","article-title":"Rethinking screening for thyroid autoimmunity in vitiligo","volume":"75","author":"Liu","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5114\/pdia.2014.43497","article-title":"Current aspects of vitiligo genetics","volume":"31","author":"Czajkowski","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1055\/s-0029-1214415","article-title":"The genetics of autoimmune thyroid disease","volume":"41","author":"Weetman","year":"2009","journal-title":"Horm Metab Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1089\/thy.2010.1643","article-title":"Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease","volume":"20","author":"Spritz","year":"2010","journal-title":"Thyroid"},{"key":"B82","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng.2272","article-title":"Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo","volume":"44","author":"Jin","year":"2012","journal-title":"Nat Genet"},{"key":"B83","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrendo.2013.56","article-title":"GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis","volume":"9","author":"Simmonds","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e1004123","DOI":"10.1371\/journal.pgen.1004123","article-title":"Identification of novel genetic loci associated with thyroid peroxidase antibodies and clinical thyroid disease","volume":"10","author":"Medici","year":"2014","journal-title":"PLoS Genet"},{"key":"B85","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/08916934.2013.768617","article-title":"Polymorphisms in NLRP1 gene and susceptibility to autoimmune thyroid disease","volume":"46","author":"Alkhateeb","year":"2013","journal-title":"Autoimmunity"},{"key":"B86","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/hmg\/11.6.661","article-title":"Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2","volume":"11","author":"Alkhateeb","year":"2002","journal-title":"Hum Mol Genet"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1086\/375451","article-title":"A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci","volume":"72","author":"Fain","year":"2003","journal-title":"Am J Hum Genet"},{"key":"B88","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1086\/381134","article-title":"Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis","volume":"74","author":"Spritz","year":"2004","journal-title":"Am J Hum Genet"},{"key":"B89","doi-asserted-by":"publisher","first-page":"E1335","DOI":"10.1210\/jc.2015-2126","article-title":"A novel FoxD3 variant is associated with vitiligo and elevated thyroid auto-antibodies","volume":"100","author":"Schunter","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B90","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00403-016-1641-z","article-title":"Hashimoto\u2019s thyroiditis could be secondary to vitiligo: the possibility of antigen crossover and oxidative stress between the two diseases","volume":"308","author":"Gong","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1046\/j.1523-1747.2002.19617.x","article-title":"Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin","volume":"119","author":"Slominski","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/jid.2009.180","article-title":"TSH receptor and thyroid-specific gene expression in human skin","volume":"130","author":"Cianfarani","year":"2010","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00290\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T00:22:49Z","timestamp":1509063769000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00290\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,27]]},"references-count":92,"alternative-id":["10.3389\/fendo.2017.00290"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2017.00290","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,27]]},"article-number":"290"}}